- Home
- CCG vs STTK Comparison
CCG vs STTK Comparison
Compare CCG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- STTK
- Stock Information
- Founded
- CCG 2014
- STTK 2016
- Country
- CCG China
- STTK United States
- Employees
- CCG N/A
- STTK N/A
- Industry
- CCG
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- STTK Health Care
- Exchange
- CCG Nasdaq
- STTK Nasdaq
- Market Cap
- CCG 67.6M
- STTK 56.8M
- IPO Year
- CCG N/A
- STTK 2020
- Fundamental
- Price
- CCG $0.91
- STTK $1.37
- Analyst Decision
- CCG
- STTK Hold
- Analyst Count
- CCG 0
- STTK 3
- Target Price
- CCG N/A
- STTK $2.00
- AVG Volume (30 Days)
- CCG 218.6K
- STTK 131.9K
- Earning Date
- CCG 03-27-2025
- STTK 03-03-2025
- Dividend Yield
- CCG N/A
- STTK N/A
- EPS Growth
- CCG N/A
- STTK N/A
- EPS
- CCG N/A
- STTK N/A
- Revenue
- CCG $478,620,143.00
- STTK $6,435,000.00
- Revenue This Year
- CCG N/A
- STTK $313.04
- Revenue Next Year
- CCG $1.24
- STTK N/A
- P/E Ratio
- CCG N/A
- STTK N/A
- Revenue Growth
- CCG 4.67
- STTK 382.75
- 52 Week Low
- CCG $0.56
- STTK $0.94
- 52 Week High
- CCG $5.27
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- CCG 58.41
- STTK 60.23
- Support Level
- CCG $0.85
- STTK $1.21
- Resistance Level
- CCG $0.93
- STTK $1.36
- Average True Range (ATR)
- CCG 0.04
- STTK 0.10
- MACD
- CCG 0.00
- STTK 0.01
- Stochastic Oscillator
- CCG 80.20
- STTK 90.00
About CCG Cheche Group Inc.
Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.